Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice

Keyphrases

• Viral Load 100%
• Tissue Regeneration 100%
• Respiratory Syncytial Virus Infection 100%
• Lung Inflammation 100%
• Protectins 100%
• Protectin D1 100%
• Respiratory Syncytial Virus 45%
• Lung 36%
• Post-infection 27%
• Mouse Lung 18%
• Intranasal 18%
• Cysteinyl Leukotrienes 18%
• Interferon lambda (IFN-λ) 18%
• Viral 9%
• Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) 9%
• Inflammation 9%
• Viral Infection 9%
• Infection Rate 9%
• Natural Killer Cells 9%
• Viral Genome 9%
• Mouse Model 9%
• Eosinophils 9%
• Lung Tissue 9%
• Eosinophil Cells 9%
• Lung Injury 9%
• Host Response 9%
• Distinct Mechanism 9%
• Neutrophil Cells 9%
• CD4+ T Cells 9%
• Antimicrobial Peptides 9%
• Cathelicidin 9%
• Interleukin-13 (IL-13) 9%
• Viral Clearance 9%
• Early Infection 9%
• Human Bronchial Epithelial Cells 9%
• NKG2D 9%
• Dysregulated 9%
• Interferon-γ Production 9%
• Pro-resolving Mediators 9%
• Activated NK Cells 9%

Immunology and Microbiology

• Viral Load 100%
• Pulmonary Inflammation 100%
• Tissue Regeneration 100%
• Respiratory Syncytial Virus Infection 100%
• Human Respiratory Syncytial Virus 25%
• Natural Killer Cell 10%
• interferon 10%
• Eosinophil 10%
• Peptidoleukotriene 10%
• Tandem Mass Spectrometry 5%
• Viral Disease 5%
• Immune Response 5%
• Mediator 5%
• Neutrophil 5%
• Mouse Model 5%
• Liquid Chromatography 5%
• T-Helper Cell 5%
• Antimicrobial Peptides 5%
• Interferon Gamma 5%
• NKG2D 5%
• Viral Clearance 5%
• Cathelicidin 5%

Pharmacology, Toxicology and Pharmaceutical Science

• CD59 Antigen 100%
• Virus Pneumonia 10%